With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Expanding access to new agents for children with refractory cancers: the experimental therapeutics program at Children's Hospital of Colorado.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2009||Colorado|
|Expanding Access to New Agents for Cancer Treatment.||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2006||Colorado|
|Children's Hospital Colorado Experimental Therapeutics Program||Children's Hospital Colorado / Lia Gore, MD||Phase I/II Infrastructure Grants||2013||Colorado|
|Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma||Children's Hospital Los Angeles / Robert Seeger, MD & Alan Wayne, MD||Innovation Grants||2015||California|
|New Approaches to Neuroblastoma Therapy (NANT) Consortium||Children's Hospital Los Angeles / Robert Seeger, MD||Phase I/II Infrastructure Grants||2006||California|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|New Approaches to Neuroblastoma Therapy||Children's Hospital Los Angeles / Robert Seeger||Phase I/II Infrastructure Grants||2008||California|
|Preclinical Studies of Gli1 Inhibition in Ewing Family Tumors||Children's Hospital Los Angeles / William May||Innovation Grants||2008||California|
|The role of OCT4 in self-renewal signaling and drug-resistance of childhood acute lymphoblastic leukemia||Children's Hospital Los Angeles / Markus Muschen||Innovation Grants||2008||California|
|Assess the activity of ABT-737 as a single agent against neuroblastoma cell lines grown in cell culture||Children's Hospital Los Angeles / Theresa Harned, MD||Young Investigator Grants||2006||California|